Cost-effectiveness analysis of pancreatic enzyme replacement therapy in patients with pancreatic exocrine insufficiency in China
This study demonstrates that PERT is a cost-effective treatment for patients suffering from PEI in China.
Authors
- Keith Roberts (ORCID: https://orcid.org/0000-0003-1799-9829)
- Kyoo il Kim (ORCID: https://orcid.org/0000-0002-2192-9367)
- Kuirong Jiang (ORCID: https://orcid.org/0000-0002-2849-5450)
- Zhuan Liao (ORCID: https://orcid.org/0000-0001-8506-8159)
- Dafni Fragkogianni
- Han‐Soo Kim (ORCID: https://orcid.org/0000-0002-6543-2598)
- Arun Jones (ORCID: https://orcid.org/0009-0006-4705-0760)
- Joshua Byrnes (ORCID: https://orcid.org/0000-0001-6562-711X)
Institutions
- Griffith University (AU)
- Queen Elizabeth Hospital Birmingham (GB)
- Abbott (Switzerland) (CH)
- Shanghai Institute of Hematology (CN)
- Gold Coast Health (AU)
- Nanjing Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-08-13
- DOI
- https://doi.org/10.4251/wjgo.v17.i8.109544
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00